Hsa-miR-195 targets PCMT1 in hepatocellular carcinoma that increases tumor life span
- Authors
- A Esquela-Kerscher
- A Gaur
- A Kozomara
- A Krek
- A Ruepp
- A. F. Awad
- B John
- BP Lewis
- C Backes
- C Blenkiron
- C Sevignani
- C Xue
- CM Croce
- CZ Chen
- D Moradpour
- DA Chavous
- E Berezikov
- E Berezikov
- E Berezikov
- E Bernstein
- Eman El-Ahwany
- ER Lemmer
- ET Verghese
- F Xiao
- F. M. Abdel Tawab
- GA Calin
- GA Calin
- GA Calin
- GM Schratt
- H Su
- H Varnholt
- HW Hwang
- I Vastrik
- J Brennecke
- J Kruger
- J Lu
- J McLauchlan
- JD Lowenson
- JJ Zhao
- JS Lee
- KA O'Donnell
- KJ Huebscher
- LF Steel
- M Colombo
- M ElHefnawi
- M Kiriakidou
- M Rehmsmeier
- M Robert
- M. Elhefnawi
- Marwa Amer
- MN Poy
- MZ Michael
- N Kono
- N Yanaihara
- Nermen Abdel Gawad
- PM Voorhoeve
- R Garzon
- R Lorenz
- R Medina
- RC Lee
- S Kosugi
- S Okuda
- S Sassen
- S Volinia
- SA Melo
- SD Hsu
- SM Johnson
- SM Park
- SP Nana-Sinkam
- Suher Zada
- T Carver
- T Xu
- TJ Carver
- U Muckstein
- V Ambros
- V Huang
- W Huang da
- W Ritchie
- X Wang
- Y Pei
- YS Huang
- Z Klase
- Publication date
- 1 January 2014
- Publisher
- 'Springer Science and Business Media LLC'
- Doi